Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Ocrelizumab may cause pancreatitis in some patients.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

There is no standard treatment for CCCA, and practices vary widely.

Clonally expanded CD8+ T cells cause alopecia areata.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.